GATA2 and chronic myelogenous leukemia, BCR-ABL1 positive: Overexpression of GATA-2 was detected in a subset of human chronic myelogenous leukemia and human neuroblastoma samples [25, 26], while GATA-3 was shown to be highly expressed in breast cancer, lymphoma and other tumors [27, 28].